Many diseases of the nervous system are accompanied by alterations in synaptic functions. Synaptic plasticity mediated by the endogenous cannabinoid system involves the activation of the cannabinoid receptor 1 (CB1R). The principles of CB1R signaling must be understood in detail for its therapeutic exploration. We detected the Src homology 3-domain growth factor receptor-bound 2-like (endophilin) interacting protein 1 (SGIP1) as a novel CB1R partner. SGIP1 is functionally linked to clathrin-mediated endocytosis and its overexpression in animals leads to an energy regulation imbalance resulting in obesity. We report that SGIP1 prevents the endocytosis of activated CB1R and that it alters signaling via the CB1R in a biased manner. CB1R mediated G-protein activation is selectively influenced by SGIP1, β-arrestin associated signaling is changed profoundly, most likely as a consequence of the prevention of the receptor's internalization elicited by SGIP1.

• Klíčová slova
• Bias signaling, Cannabinoid receptor 1, G-protein coupled receptors, Protein-protein interactions, Receptor endocytosis, Seven transmembrane receptors,
• MeSH
• adaptorové proteiny signální transdukční MeSH
• beta arrestin 2 metabolismus   MeSH
• buněčná membrána účinky léků   metabolismus   MeSH
• endocytóza účinky léků   fyziologie   MeSH
• HEK293 buňky MeSH
• lidé MeSH
• MAP kinasový signální systém fyziologie   MeSH
• mozek metabolismus   MeSH
• myši MeSH
• neurony metabolismus   MeSH
• potkani Wistar MeSH
• receptor kanabinoidní CB1 metabolismus   MeSH
• Saccharomyces cerevisiae MeSH
• techniky dvojhybridového systému MeSH
• transfekce MeSH
• transportní proteiny genetika   metabolismus   MeSH
• zvířata MeSH
• Check Tag
• lidé MeSH
• myši MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• adaptorové proteiny signální transdukční MeSH
• beta arrestin 2 MeSH
• receptor kanabinoidní CB1 MeSH
• SGIP1 protein, mouse MeSH Prohlížeč
• transportní proteiny MeSH

The differential signaling of multiple FGF ligands through a single fibroblast growth factor (FGF) receptor (FGFR) plays an important role in embryonic development. Here, we use quantitative biophysical tools to uncover the mechanism behind differences in FGFR1c signaling in response to FGF4, FGF8, and FGF9, a process which is relevant for limb bud outgrowth. We find that FGF8 preferentially induces FRS2 phosphorylation and extracellular matrix loss, while FGF4 and FGF9 preferentially induce FGFR1c phosphorylation and cell growth arrest. Thus, we demonstrate that FGF8 is a biased FGFR1c ligand, as compared to FGF4 and FGF9. Förster resonance energy transfer experiments reveal a correlation between biased signaling and the conformation of the FGFR1c transmembrane domain dimer. Our findings expand the mechanistic understanding of FGF signaling during development and bring the poorly understood concept of receptor tyrosine kinase ligand bias into the spotlight.

• Klíčová slova
• FGFR, biased signaling, molecular biophysics, none, signal transduction, structural biology,
• MeSH
• fibroblastové růstové faktory * MeSH
• fosforylace MeSH
• lidé MeSH
• ligandy MeSH
• receptor fibroblastových růstových faktorů, typ 1 genetika   MeSH
• signální transdukce * MeSH
• těhotenství MeSH
• zkreslení výsledků (epidemiologie) MeSH
• Check Tag
• lidé MeSH
• těhotenství MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• FGFR1 protein, human MeSH Prohlížeč
• fibroblastové růstové faktory * MeSH
• ligandy MeSH
• receptor fibroblastových růstových faktorů, typ 1 MeSH

The Cannabis sativa plant has been used for centuries as a recreational drug and more recently in the treatment of patients with neurological or psychiatric disorders. In many instances, treatment goals include relief from posttraumatic disorders, anxiety, or to support treatment of chronic pain. Ligands acting on cannabinoid receptor 1 (CB1R) are also potential targets for the treatment of other health conditions. Using an evidence-based approach, pharmacological investigation of CB1R agonists is timely, with the aim to provide chronically ill patients relief using well-defined and characterized compounds from cannabis. Hexahydrocannabinol (HHC), currently available over the counter in many countries to adults and even children, is of great interests to policy makers, legal administrators, and healthcare regulators, as well as pharmacologists. Herein, we studied the pharmacodynamics of HHC epimers, which activate CB1R. We compared their key CB1R-mediated signaling pathway activities and compared them to the pathways activated by Δ9-tetrahydrocannabinol (Δ9-THC). We provide evidence that activation of CB1R by HHC ligands is only broadly comparable to those mediated by Δ9-THC, and that both HHC epimers have unique properties. Together with the greater chemical stability of HHC compared to Δ9-THC, these molecules have a potential to become a part of modern medicine.

• MeSH
• agonisté kanabinoidních receptorů farmakologie   MeSH
• HEK293 buňky MeSH
• kanabinol farmakologie   MeSH
• lidé MeSH
• myši MeSH
• receptor kanabinoidní CB1 * metabolismus   agonisté   MeSH
• signální transdukce * účinky léků   MeSH
• tetrahydrokanabinol * farmakologie   MeSH
• zvířata MeSH
• Check Tag
• lidé MeSH
• myši MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Research Support, N.I.H., Extramural MeSH
• Názvy látek
• agonisté kanabinoidních receptorů MeSH
• kanabinol MeSH
• receptor kanabinoidní CB1 * MeSH
• tetrahydrokanabinol * MeSH

Interleukin-2 is a pleiotropic cytokine that mediates both pro- and anti-inflammatory functions. Immune cells naturally differ in their sensitivity to IL-2 due to cell type and activation state-dependent expression of receptors and signaling pathway components. To probe differences in IL-2 signaling across cell types, we used structure-based design to create and profile a series of IL-2 variants with the capacity to titrate maximum signal strength in fine increments. One of these partial agonists, IL-2-REH, specifically expanded Foxp3+ regulatory T cells with reduced activity on CD8+ T cells due to cell type-intrinsic differences in IL-2 signaling. IL-2-REH elicited cell type-dependent differences in gene expression and provided mixed therapeutic results: showing benefit in the in vivo mouse dextran sulfate sodium (DSS) model of colitis, but no therapeutic efficacy in a transfer colitis model. Our findings show that cytokine partial agonists can be used to calibrate intrinsic differences in response thresholds across responding cell types to narrow pleiotropic actions, which may be generalizable to other cytokine and growth factor systems.

• Klíčová slova
• IL-2, biochemistry, chemical biology, cytokine signaling, human, immunology, inflammation, mouse,
• MeSH
• buněčné linie MeSH
• CD8-pozitivní T-lymfocyty metabolismus   MeSH
• cytokiny metabolismus   MeSH
• interleukin-2 agonisté   metabolismus   MeSH
• kolitida chemicky indukované   MeSH
• modely nemocí na zvířatech MeSH
• myši inbrední C57BL MeSH
• myši MeSH
• regulační T-lymfocyty metabolismus   MeSH
• signální transdukce * MeSH
• zvířata MeSH
• Check Tag
• myši MeSH
• ženské pohlaví MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Research Support, N.I.H., Extramural MeSH
• Research Support, U.S. Gov't, Non-P.H.S. MeSH
• Názvy látek
• cytokiny MeSH
• interleukin-2 MeSH

Disruption of cholinergic signalling via muscarinic receptors is associated with various pathologies, like Alzheimer's disease or schizophrenia. Selective muscarinic agonists possess therapeutic potential in the treatment of diabetes, pain or Sjögren's syndrome. The orthosteric binding site of all subtypes of the muscarinic receptor is structurally identical, making the development of affinity-based selective agonists virtually impossible. Some agonists, however, are functionally selective; they activate only a subset of receptors or signalling pathways. Others may stabilise specific conformations of the receptor leading to non-uniform modulation of individual signalling pathways (biased agonists). Functionally selective and biased agonists represent a promising approach for selective activation of individual subtypes of muscarinic receptors. In this work we review chemical structures, receptor binding and agonist-specific conformations of currently known functionally selective and biased muscarinic agonists in the context of their intricate intracellular signalling. Further, we take a perspective on the possible use of biased agonists for tissue and organ-specific activation of muscarinic receptors.

• Klíčová slova
• Functional selectivity, G-proteins, Muscarinic receptors, Signalling bias, β-arrestins,
• MeSH
• agonisté muskarinových receptorů farmakologie   MeSH
• lidé MeSH
• receptory muskarinové účinky léků   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• přehledy MeSH
• Názvy látek
• agonisté muskarinových receptorů MeSH
• receptory muskarinové MeSH

BACKGROUND AND PURPOSE: More than 30% of currently marketed medications act via GPCRs. Thus, GPCRs represent one of the most important pharmacotherapeutic targets. In contrast to traditional agonists activating multiple signalling pathways, agonists activating a single signalling pathway represent a new generation of drugs with increased specificity and fewer adverse effects. EXPERIMENTAL APPROACH: We have synthesized novel agonists of muscarinic ACh receptors and tested their binding and function (on levels of cAMP and inositol phosphates) in CHO cells expressing individual subtypes of muscarinic receptors, primary cultures of rat aortic smooth muscle cells and suspensions of digested native tissues from rats. Binding of the novel compounds to M2 receptors was modelled in silico. KEY RESULTS: Two of the tested new compounds (1-(thiophen-2-ylmethyl)-3,6-dihydro-2H-pyridinium and 1-methyl-1-(thiophen-2-ylmethyl)-3,6-dihydro-2H-pyridinium) only inhibited cAMP synthesis in CHO cells, primary cultures, and native tissues, with selectivity for M2 muscarinic receptors and displaying bias towards the Gi signalling pathway at all subtypes of muscarinic receptors. Molecular modelling revealed interactions with the orthosteric binding site in a way specific for a given agonist followed by agonist-specific changes in the conformation of the receptor. CONCLUSIONS AND IMPLICATIONS: The identified compounds may serve as lead structures in the search for novel non-steroidal and non-opioid analgesics acting via M2 and M4 muscarinic receptors with reduced side effects associated with activation of the phospholipase C signalling pathway.

• MeSH
• agonisté muskarinových receptorů * farmakologie   MeSH
• antagonisté muskarinových receptorů farmakologie   MeSH
• CHO buňky MeSH
• Cricetulus MeSH
• křečci praví MeSH
• krysa rodu Rattus MeSH
• receptor muskarinový M2 MeSH
• receptory muskarinové * MeSH
• signální transdukce MeSH
• zvířata MeSH
• Check Tag
• křečci praví MeSH
• krysa rodu Rattus MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• agonisté muskarinových receptorů * MeSH
• antagonisté muskarinových receptorů MeSH
• receptor muskarinový M2 MeSH
• receptory muskarinové * MeSH

We report on an intrinsic relationship between the maximum-likelihood quantum-state estimation and the representation of the signal. A quantum analogy of the transfer function determines the space where the reconstruction should be done without the need for any ad hoc truncations of the Hilbert space. An illustration of this method is provided by a simple yet practically important tomography of an optical signal registered by realistic binary detectors.

• Publikační typ
• časopisecké články MeSH

Thyrotropin-releasing hormone (TRH) is an important endocrine agent that regulates the function of cells in the anterior pituitary and the central and peripheral nervous systems. By controlling the synthesis and release of thyroid hormones, TRH affects many physiological functions, including energy homeostasis. This hormone exerts its effects through G protein-coupled TRH receptors, which signal primarily through Gq/11 but may also utilize other G protein classes under certain conditions. Because of the potential therapeutic benefit, considerable attention has been devoted to the synthesis of new TRH analogs that may have some advantageous properties compared with TRH. In this context, it may be interesting to consider the phenomenon of biased agonism and signaling at the TRH receptor. This possibility is supported by some recent findings. Although knowledge about the mechanisms of TRH receptor-mediated signaling has increased steadily over the past decades, there are still many unanswered questions, particularly about the molecular details of post-receptor signaling. In this review, we summarize what has been learned to date about TRH receptor-mediated signaling, including some previously undiscussed information, and point to future directions in TRH research that may offer new insights into the molecular mechanisms of TRH receptor-triggered actions and possible ways to modulate TRH receptor-mediated signaling.

• Klíčová slova
• G protein, TRH receptors, signaling, thyrotropin-releasing hormone, β-arrestin,
• Publikační typ
• časopisecké články MeSH
• přehledy MeSH

f-statistics have emerged as a first line of analysis for making inferences about demographic history from genome-wide data. Not only are they guaranteed to allow robust tests of the fits of proposed models of population history to data when analyzing full genome sequencing data-that is, all single nucleotide polymorphisms (SNPs) in the individuals being analyzed-but they are also guaranteed to allow robust tests of models for SNPs ascertained as polymorphic in a population that is an outgroup in a phylogenetic sense to all groups being analyzed. True "outgroup ascertainment" is in practice impossible in humans because our species has arisen from a substructured ancestral population that does not descend from a homogeneous ancestral population going back many hundreds of thousands of years into the past. However, initial studies suggested that non-outgroup-ascertainment schemes might produce robust enough results using f-statistics, and that motivated widespread fitting of models to data using non-outgroup-ascertained SNP panels such as the "Affymetrix Human Origins array" which has been genotyped on thousands of modern individuals from hundreds of populations, or the "1240k" in-solution enrichment reagent which has been the source of about 70% of published genome-wide data for ancient humans. In this study, we show that while analyses of population history using such panels work well for studies of relationships among non-African populations and one African outgroup, when co-modeling more than one sub-Saharan African and/or archaic human groups (Neanderthals and Denisovans), fitting of f-statistics to such SNP sets is expected to frequently lead to false rejection of true demographic histories, and failure to reject incorrect models. Analyzing panels of SNPs polymorphic in archaic humans, which has been suggested as a solution for the ascertainment problem, has limited statistical power and retains important biases. However, by carrying out simulations of diverse demographic histories, we show that bias in inferences based on f-statistics can be minimized by ascertaining on variants common in a union of diverse African groups; such ascertainment retains high statistical power while allowing co-analysis of archaic and modern groups.

• MeSH
• Afričané * genetika   MeSH
• biologická variabilita populace genetika   MeSH
• černoši genetika   MeSH
• demografie * dějiny   MeSH
• fylogeneze * MeSH
• genotyp MeSH
• jednonukleotidový polymorfismus * genetika   MeSH
• lidé MeSH
• mapování chromozomů MeSH
• neandertálci genetika   MeSH
• statistické modely MeSH
• zkreslení výsledků (epidemiologie) MeSH
• zvířata MeSH
• Check Tag
• lidé MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Research Support, N.I.H., Extramural MeSH

In dichotic listening, two different signals are played to a subject separately to the left and the right ear at the same time. The subject's reports of what he or she has understood are recorded and the efficiency of one or the other ear is expressed as a laterality quotient called "ear advantage." In this study, using consonant-vowel syllable pairs as stimuli, the extent to which each syllable in a pair gains against the other during recognition was measured. As the results show that this so-called stimulus-dominance effect is strong, a method is proposed to unbias the results. The method rests on the assumption that when the same recording is replayed to the subject once again with the headphones reversed, and the response to a particular syllable pair in both runs is in favor of syllable and not side, the response can be qualified as stimulus biased and discarded.

• MeSH
• akustická stimulace MeSH
• dichotické testy * MeSH
• dospělí MeSH
• fonetika MeSH
• funkční lateralita * MeSH
• lidé MeSH
• mozek fyziologie   MeSH
• pozornost MeSH
• sluch fyziologie   MeSH
• Check Tag
• dospělí MeSH
• lidé MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH